Tarsus Pharmaceuticals (TARS) EPS (Basic) (2019 - 2026)
Tarsus Pharmaceuticals (TARS) posted quarterly EPS (Basic) of -$0.16 for Q1 2026, up 74.66% year-over-year from -$0.09 in Q1 2025, and down 19.33% quarter-over-quarter from -$0.14 in Q4 2025.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) EPS (Basic) (2019 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.16 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 74.66% year-over-year to -$0.16; the TTM figure through Mar 2026 stood at -$3.47 (down 32.59% YoY), while the FY2025 annual figure was -$1.59, up 48.27% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.16, down from -$0.14 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.14 in Q4 2025, with the low at -$2.92 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.83 (2024), against an average of -$0.86.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) sank 420.95% in 2023, then surged 77.99% in 2025.
- Tarsus Pharmaceuticals' EPS (Basic) stood at -$0.55 in 2022, then tumbled by 160.22% to -$1.44 in 2023, then jumped by 57.37% to -$0.61 in 2024, then soared by 77.99% to -$0.14 in 2025, then slipped by 19.33% to -$0.16 in 2026.
- Business Quant data shows TARS's EPS (Basic) at -$0.16 in Q1 2026, -$0.14 in Q4 2025, and -$0.3 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Tarsus Pharmaceuticals | 3.96 Bn | 3.51 Bn | 161.80 Mn | -0.49 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.49 |
| Mar 31, 2026 | -0.16 |
| Dec 31, 2025 | -0.15 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.64 |
| Dec 31, 2024 | -0.61 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.83 |
| Mar 31, 2024 | -1.01 |
| Dec 31, 2023 | -1.45 |
| Sep 30, 2023 | -1.27 |
| Jun 30, 2023 | -1.17 |
| Mar 31, 2023 | -0.87 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -0.84 |
| Jun 30, 2022 | -0.22 |
| Mar 31, 2022 | -0.96 |
| Dec 31, 2021 | -0.70 |
| Sep 30, 2021 | -0.74 |